Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2013 Oct 30;8(10):e77292. doi: 10.1371/journal.pone.0077292

RNA-Sequencing Analysis of TCDD-Induced Responses in Zebrafish Liver Reveals High Relatedness to In Vivo Mammalian Models and Conserved Biological Pathways

Zhi-Hua Li 1,2, Hongyan Xu 1, Weiling Zheng 1, Siew Hong Lam 1, Zhiyuan Gong 1,*
Editor: Zhanjiang Liu3
PMCID: PMC3813628  PMID: 24204792

Abstract

TCDD is one of the most persistent environmental toxicants in biological systems and its effect through aryl hydrocarbon receptor (AhR) has been well characterized. However, the information on TCDD-induced toxicity in other molecular pathways is rather limited. To fully understand molecular toxicity of TCDD in an in vivo animal model, adult zebrafish were exposed to TCDD at 10 nM for 96 h and the livers were sampled for RNA-sequencing based transcriptomic profiling. A total of 1,058 differently expressed genes were identified based on fold-change>2 and TPM (transcripts per million) >10. Among the top 20 up-regulated genes, 10 novel responsive genes were identified and verified by RT-qPCR analysis on independent samples. Transcriptomic analysis indicated several deregulated pathways associated with cell cycle, endocrine disruptors, signal transduction and immune systems. Comparative analyses of TCDD-induced transcriptomic changes between fish and mammalian models revealed that proteomic pathway is consistently up-regulated while calcium signaling pathway and several immune-related pathways are generally down-regulated. Finally, our study also suggested that zebrafish model showed greater similarity to in vivo mammalian models than in vitro models. Our study indicated that the zebrafish is a valuable in vivo model in toxicogenomic analyses for understanding molecular toxicity of environmental toxicants relevant to human health. The expression profiles associated with TCDD could be useful for monitoring environmental dioxin and dioxin-like contamination.

Introduction

Dioxin-like compounds are major environmental contaminants that could pose serious threats to public health and the ecosystem [1]. Since 1980s, it has been increasingly documented that dioxin-like compounds cause various biological effects in laboratory animals and human [2], [3]. Among them, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is the most potent toxicant and it is produced from both natural and anthropogenic processes including incineration of chlorine-containing substances, bleaching of paper, manufacturing of specific organochlorine chemicals, volcanoes, and forest fires [4]. As an aromatic hydrocarbon, TCDD has a long biological half-life and is heavily accumulated in the food chain, which causes adverse effects on human health at environmental levels [4], [5]. Till now, many animal models, including fishes, have been used in TCDD studies [6], [7]. However, most of these studies have focused on the physiological-biochemical parameters and typical molecular markers, such as the gene cyp1a and the Aryl hydrocarbon receptor (AhR) signaling pathway [7] and detailed molecular toxicity of TCDD remains to be elucidated.

Genomic approaches have been increasingly used in toxicological research in the past decade. Previous toxicogenomic studies mostly used DNA microarray technology to capture the global gene expression data and to evaluate the effects of toxicant exposure [8], [9]. However, there are several drawbacks in microarray analysis, e.g. limited sensitivity, probe cross-hybridization, incomplete genome coverage and a prerequisite for sequence information in order to include new probes [10]. Recently, the advent of next-generation sequencing (NGS) technologies has significantly accelerated genomic research and provided a better alternative for transcriptomic analysis [11]. By high-throughput RNA sequencing, it is feasible to measure transcript abundance and transcriptomic profiles with a broad dynamic range, therefore providing a powerful tool to determine the potential adverse effects of environmental contaminants on public health [8].

Comparative studies across different taxonomic groups are important not only in understanding of organism diversity but also for inferring important biological responses due to evolutionary conservation [4]. In toxicology, animal models are widely used to infer human responses to chemical exposure. Particularly, it is valuable to use multiple animal models for comparative analyses in order to determine conserved adverse responses or molecular events. As lower vertebrates in evolution, fishes are particularly important models for such comparative studies [12], [13]. Now the zebrafish (Danio rerio) has become an increasingly popular model in human disease studies because of its many advantageous properties in laboratory experiments, such as its small size and easy availability in a large number, short generation time for genetic manipulation, and cost effectiveness for high-throughput studies. More importantly, many molecular and developmental studies have shown that zebrafish and human share many common genes in conserved developmental pathways in organogenesis and related physiological processes as well as in carcinogenesis [14], [15].

As there is so far no NGS based transcriptomic analysis for molecular response to TCDD treatment, in the present study we carried out RNA sequencing analyses of TCDD-treated in order to carry out a genome-wide identification of novel TCDD responsive genes and pathways, which should provide a comprehensive understanding of the molecular mechanism of TCDD-induced toxicity in mammals and human. We further compared the zebrafish response with those from mammalian systems and thus identified common molecular pathways deregulated in both fish and mammals. We found that the zebrafish model is more similar to mammalian in vivo models than in vitro models, thus indicating a validity of the zebrafish as an emerging in vivo model in comparative toxicological research.

Materials and Methods

Zebrafish

Experimental procedures were carried out following the approved protocol by Institutional Animal Care and Use Committee of National University of Singapore (Protocol 079/07). Adult zebrafish (3-month old), which are Singapore wild type zebrafish, were purchased from a local aquarium farm (Mainland Tropical Fish Farm, Singapore) and acclimated for at least one week in our aquarium before chemical exposure experiment. Fish were maintained at ambient temperature of around 28°C with a 14-h light and 10-h dark cycle in a flow-through water system.

Chemical exposure

TCDD was purchased from Sigma-Aldrich (USA) and dissolved in dimethyl sulfoxide (DMSO). Male adult fish were used in the exposure experiments by immersing in the TCDD water (10 nM) for 96 h at ambient temperature (28°C) in a static condition. Control fish were kept in water with 0.01% DMSO (vehicle) under the same condition. Water was changed daily throughout the treatment. After 96 hours of chemical exposure, treated and control fish were sacrificed and liver samples were dissected from each fish.

RNA sample preparation and SAGE library sequencing

Total RNA was extracted from livers (excluding gall bladders) of individual fish using TRIzol® Reagent (Invitrogen) and treated with DNase I (Invitrogen) to remove genomic DNA contamination. For RNA sequencing, RNA was pooled equally from 9 fish for each group (TCDD and control). Poly A+ RNA was purified using Dynabeads® Oligo (dT) EcoP (Invitrogen) and subjected to cDNA synthesis. Synthesized cDNA was digested by NlaIII and sequencing adapters were added to the cDNA fragments. SAGE (serial analysis of gene expression) sequencing (tag length = 27 nucleotides) was performed by Mission Biotech (Taiwan) with ABI SOLiDTM System 2.0 (Applied Biosystems). The RNA-sep data reported in the present study was submitted to Gene Expression Omnibu with an access number GSE49915.

Gene annotation and selection of differentially expressed genes

All SAGE tags were mapped to the zebrafish Reference Sequence database (http://www.ncbi.nlm.nih.gov/RefSeq) with maximum 2 nucleotide mismatch. Uniquely mapped tag counts for each transcript were normalized to TPM (transcripts/tags per million). For biological implication analyses, genes with only marginal expression, as defined by TPM<10 in both control and TCDD groups, were excluded. As it has been previously reported that the actual measured quantity of differential expression (fold change or ratio) is more consistent and reproducible in identifying differentially expressed genes than the statistical significance (p-value) [16], [17], in the present study, we selected differentially expressed genes based on fold change>2 and TPM>10.

Gene Ontology enrichment analysis

Gene ontology enrichment analysis was performed using DAVID (The Database for Annotation, Visualization and Integrated Discovery) with the total zebrafish genome information as the background and p-values based on a modified Fisher's exact t-test. Gene Ontology Fat categories were used for this analysis and the cut-off p-value is 0.05.

Real-time PCR

Real-time PCR was performed using the LightCycler system (Roche Applied Science) with LightCycler FastStart DNA Master SYBR Green I (Roche Applied Science) according to the manufacturer's instruction. For comparison between real-time PCR and RNA-seq results, Cp (crossing point value) and TPM values for each gene were normalized against Cp and TPM of β-actin1 (GI_ID:18858334).

Analysis of the hepatic enriched gene list by GSEA and IPA analysis

GSEA (Gene Set Enrichment Analysis) pre-ranked option was used to analyze the entire set of differentially expressed genes (651 up- and 407 down-regulated genes). Briefly, the gene symbols of human homologs of the enriched zebrafish Unigene clusters were ranked using logarithm transformed fold change (base 2). The number of permutation used was 1000. Pathways with false discovery rate (FDR) <0.25 were considered statistically significant. For IPA (Ingenuity Pathway Analysis), the same set of differentially expressed genes was uploaded to online Ingenuity Pathways Knowledge Base for functional implication analyses.

Cross-species comparison

Six sets of transcriptomic data for in vivo and in vitro mammalian models treated by TCDD (GSE10082, GSE10083, GSE10769, GSE10770, GSE14555 and GSE34251) were retrieved from GEO (Gene Expression Omnibus). GSEA was used to establish the relatedness between zebrafish and mammalian models. The zebrafish hepatic transcriptome lists were converted into human and mouse homolog Unigene clusters. The statistical significance of the enrichment score was estimated by using an empirical phenotype-based permutation test. An FDR value was provided by introducing adjustment of multiple hypothesis testing.

Results and Discussion

General features of SAGE tags in TCDD-treated and control groups

There were 11.7 million and 17.9 million SAGE sequence tags generated from the DMSO vehicle control and TCDD-treated groups, respectively. About 2.7 million tags in the control group and 3.2 million tags in the TCDD group could be mapped with the known transcripts. The mapped tags were normalized to transcripts per million (TPM) and the expression level of genes ranged from 0.3 to 110844.2 TPM in the two groups, indicating a dynamic range of more than six orders of magnitude in transcript abundance. As shown in Figure 1A, transcript abundance profiles in both groups were very similar. The transcriptomes consist of a small number of high abundant transcripts and a large number of low abundant transcripts, similar to those reported in many previous RNA-seq studies [18], [19]. The percentages of the transcripts with relatively high expression level (TPM>256) were 3.8% in the TCDD group and 3.1% in the control group, but contributed to 80.4% and 83.0% of the total transcripts respectively. In contrast, the percentages of the transcripts with the low expression level (TPM<16) were 67.1% and 76.3% in the TCDD group and control group, contributing only 3.1% and 3.2% of the total transcripts.

Figure 1. Comparison of transcriptomic profiles between TCDD and control groups.

Figure 1

(A) Distribution of transcript entries and total transcript counts over different tag abundance categories in liver of zebrafish. The percentages of total transcript counts and number of different transcript entries per category are plotted on a log scale (base10). (B) Relationship between the hepatic transcriptome changing range and its expression level in zebrafish after TCDD treatment. The base of log value is 2.

Differentially expressed genes in response to TCDD and their gene ontology profile

Figure 1B shows the relationship between the dynamic transcript fold-change of hepatic transcriptome and its expression level in zebrafish treated by TCDD. Differentially expressed genes after TCDD treatment were first determined by comparison of the two sets of mapped SAGE tags with fold-change>2 and TPM >10. In total, 1,058 genes were identified, including 651 up-regulated genes and 407 down-regulated genes. The top 20 most up-regulated transcripts based on fold-change are listed in the Table 1. After compared with TCDD responsive genes in CTD (The Comparative Toxicogenomics Database, http://ctdbase.org/), ten gens (cyp1a, ahrra, actc1b, odf3b, mid1ip1, pklr, lrrc23, ccdc113, sdf2, and fgf13) have been reported to be related in fish and/or mammalian models after TCDD exposure among the top 20 genes. Not surprisingly, cyp1a, the best known molecular marker for TCDD exposure [20], was the most up-regulated gene (151.4 fold) in the list, indicating that our TCDD treatment in the experiment was effective. It is interesting to note that adrra (aryl hydrocarbon receptor repressor a) is the second highest up-regulated gene, while the two aryl hydrocarbon receptor genes (ahr1a and ahr2) were not significantly up-regulated in our RNA-seq data with a modest 50% increase for adr2 and slightly decrease for adr1a (data not shown), 10 novel TCDD-responsive genes, eight annotated (rab36, sycp3l, rnasel2, tnni2b.2, hormad1, tuba7l, irak1bp1 and zgc:152916,) and two unannotated (zgc:193690 and si:dkey-190g11.7), have been identified from the top 20 most up-regulated genes. To confirm their inducibility of the 20 genes by TCDD, real-time PCR was carried out with individual fish liver samples from an independent set of TCDD treatment experiment. As shown in Figure 2, 17 out of 20 genes showed up-regulation in at least three individual samples; among them, 13 genes had up-regulation in all of the five individual samples. Thus, our RT-qPCR data indicated a strong agreement with the RNA-sequencing data and, more importantly, the validation was from five independent biological samples. Interestingly, all of the 10 novel TCDD responsive genes found in the present study were validated by RT-qPCR (Figure 2). Thus, our RNA-seq data provided additional biomarker genes for TCDD exposure. Among these validated biomarker genes, several of them apparently encodes secreted protein (e.g. fgf13b and rnasel2) and their protein products are also likely present in the circulating blood and may offer convenient non-invasive assays for detection of TCDD exposure. A notable exception in the validation experimental data was lrrc23 that was constantly down-regulated in all five individuals, indicating that irrc23 is not a reproducibly up-regulated gene by TCDD. In future, these novel molecular markers for TCDD exposure can be further tested for their time- and dose-responsiveness.

Table 1. Top up-regulated genes by TCDD in zebrafish liver.

GI_ID Gene Symbol Gene Name TPM Value Log2FC
Control TCDD
40538769 cyp1a cytochrome P450, family 1, subfamily A 1.49 225.60 7.24
41152043 pklr pyruvate kinase, liver and RBC 0.37 28.99 6.28
78214313 ahrra aryl-hydrocarbon receptor repressor a 0.30 20.48 6.09
118722331 rab36 RAB36, member RAS oncogene family 0.37 23.32 5.97
94536666 sycp3l synaptonemal complex protein 3 like 0.30 18.27 5.93
113679002 zgc:152916 zgc:152916 0.37 20.80 5.80
154147743 rnasel2 ribonuclease like 2 12.65 641.82 5.67
192447400 zgc:193690 zgc:193690 0.30 13.55 5.50
54400609 lrrc23 leucine rich repeat containing 23 0.30 12.29 5.36
66472791 irak1bp1 interleukin-1 receptor-associated kinase 1 binding protein 1 0.30 11.97 5.32
51010936 tnni2b.2 troponin I, skeletal, fast 2b.2 0.30 11.34 5.24
54400623 ccdc113 coiled-coil domain containing 113 0.37 13.86 5.22
18858248 actc1b actin, alpha, cardiac muscle 1b 1.12 39.07 5.13
41053926 odf3b outer dense fiber of sperm tails 3B 0.37 11.66 4.97
165972470 si:dkey-190 g11.7 si:dkey-190g11.7 0.74 23.00 4.95
51230510 sdf2 stromal cell-derived factor 2 1.49 45.06 4.92
45387810 fgf13b fibroblast growth factor 13b 0.37 10.40 4.80
50539781 hormad1 HORMA domain containing 1 1.49 39.39 4.73
50345117 tuba7l tubulin, alpha 7 like 0.74 19.53 4.71
18858724 mid1ip1 MID1 interacting protein 1 0.74 18.27 4.62

Figure 2. RT-qPCR validation of top 20 up-regulated TCDD-induced genes.

Figure 2

RT-qPCR was performed from five individual liver samples collected from five fish treated by TCDD from a new experiment. The relative expression level of the genes was shown in color code as indicated on the fight and the value is in log2 fold change as compared with a housekeeping gene, β-actin1. *-only reported in fish model; #-only reported in mammalian model.

Besides cyp1a, some other genes with high abundance were also up-regulated by TCDD exposure in zebrafish (Table S1). The up-regulation of pklr (pyruvate kinase, liver and red blood cell) in our experiment was consistent with several previous reports that TCDD affects pyruvate utilization for energy and thus glycolysis and gluconeogenesis [21], [22]. Gene expression of alas1, the first and rate-limiting enzyme involved in heme biosynthesis [23], was up-regulated in our study, suggesting that the heme biosynthesis was deregulated in hepatic cells of fish exposed to TCDD. Hspa5 is a member of the heat shock protein 70 (Hsp70) family and it has been used as an endoplasmic reticulum (ER) stress sensor [24]. In our study, the expression of hspa5 was up-regulated with 10.2 fold, implying TCDD led to the ER stress and this event was a highly conserved adaptive response induced by environmental toxicants. Moreover, the gene pck1 (phosphoenolpyruvate carboxykinase 1), as a key factor in gluconeogenesis, was up-regulated 6.8 fold, indicating that TCDD exposure also affected the gluconeogenesis by altering the expression of genes encoding key gluconeogenic enzymes [25].

Through gene ontology analysis, the differentially expressed genes were classified into different categories based on GO database using DAVID software (Table 2). Among the up-regulated GO categories, the most significant ones included Endoplasmic reticulum (p-value = 1.19E-13) and Proteasome complex (p-value = 2.67E-09). Since most P450s (e.g. CYP1A enzymes) are involved in xenobiotic metabolism and primarily located in endoplasmic reticulum, it is not surprising that the TCDD-induced physiological stress occurred mainly in these cellular components, which was also supported by the up-regulated 19 genes of CYP family in our study (Table S2). Moreover, other histological studies also found TCDD led to hypertrophy of hepatocytes, glycogen depletion and lipidosis of liver in zebrafish and other fish [26], which were related to the endoplasmic reticulum (ER) stress via some cellular receptor or/and protein [27], [28]. In subsequent analysis, our results also showed that the proteasome related pathways (Proteasome pathway and HSA03050 Proteasome, see Table 3) were significantly up-regulated in zebrafish after TCDD treatment. Consistent with this, several GO categories involved in Proteasome deregulation, such as Protein folding and Cellular protein catabolic process in the Biological Process category, as well as Unfolded protein binding in the Molecular Function category, further indicating that the proteasome related bio-functions were deregulated.

Table 2. Enriched GO terms in response to TCDD treatment in zebrafish liver (p<0.01).

Category Term Count % P-Value Fold Enrichment
Biological protein folding 19 2.98 1.05E-06 3.94
process cellular macromolecule catabolic process 24 3.77 4.61E-05 2.59
macromolecule catabolic process 26 4.08 5.61E-05 2.44
proteolysis involved in cellular protein catabolic process 22 3.45 7.17E-05 2.65
cellular protein catabolic process 22 3.45 7.17E-05 2.65
modification-dependent protein catabolic process 20 3.14 1.65E-04 2.66
modification-dependent macromolecule catabolic process 20 3.14 1.65E-04 2.66
protein catabolic process 22 3.45 2.53E-04 2.43
cell cycle 19 2.98 4.11E-04 2.56
protein maturation by peptide bond cleavage 4 0.63 8.39E-04 17.76
proteolysis 41 6.44 1.40E-03 1.66
protein transport 26 4.08 1.59E-03 1.96
establishment of protein localization 26 4.08 1.59E-03 1.96
protein localization 27 4.24 1.80E-03 1.91
response to bacterium 8 1.26 2.08E-03 4.33
intracellular transport 19 2.98 2.14E-03 2.22
cellular protein localization 15 2.35 4.82E-03 2.33
cellular macromolecule localization 15 2.35 5.13E-03 2.31
Cellular endoplasmic reticulum 42 6.59 1.19E-13 3.67
component proteasome complex 16 2.51 2.67E-09 6.93
cytosol 21 3.30 6.39E-07 3.65
endoplasmic reticulum part 14 2.20 6.83E-06 4.57
endoplasmic reticulum membrane 11 1.73 1.89E-04 4.25
nuclear envelope-endoplasmic reticulum network 11 1.73 3.44E-04 3.96
proteasome core complex 6 0.94 4.41E-03 5.31
Molecular unfolded protein binding 12 1.88 2.85E-05 4.83
function oligosaccharyl transferase activity 4 0.63 5.94E-04 19.98
acid-amino acid ligase activity 12 1.88 1.74E-03 3.06
threonine-type peptidase activity 6 0.94 2.23E-03 6.24
threonine-type endopeptidase activity 6 0.94 2.23E-03 6.24
dolichyl-diphosphooligosaccharide-protein lycotransferase activity 3 0.47 4.64E-03 24.98
ligase activity, forming carbon-nitrogen bonds 13 2.04 5.65E-03 2.50
translation initiation factor activity 8 1.26 5.92E-03 3.63
heme binding 12 1.88 8.31E-03 2.50
RNA binding 20 3.14 9.61E-03 1.89

Table 3. Significantly regulated pathways in zebrafish after TCDD treatment, by GSEA analysis with cutoff FDR<0.25.

Pathways NES NOM p-value FDR q-value
G1 to S cell cycle reactome 1.94 <0.001 0.024
HSA04110 cell cycle 1.9 <0.001 0.025
Cell cycle KEGG 1.86 0.003 0.031
Proteasome pathway 1.81 0.007 0.053
HSA03050 Proteasome 1.74 0.007 0.115
HSA03010 Ribosome −2.31 <0.001 <0.001
Ribosomal proteins −2.21 <0.001 0.001
HSA04020 Calcium signaling pathway −1.85 0.005 0.126
Prostaglandin synthesis regulation −1.81 0.005 0.167
ST FAS signaling pathway −1.81 0.007 0.139
ST T cell signal transduction −1.79 <0.001 0.135
HSA04650 Natural killer cell mediated cytotoxicity −1.76 0.007 0.160
HSA04660 T cell receptor signaling pathway −1.75 0.008 0.152

Note: NES, normalized enrichment scores; NOM p-value, nominal p-value for enrichment; FDR, false discovery rate.

Change of transcription factor networks by TCDD exposure

By IPA analysis, six significant transcription factors were found to be related to TCDD-induced hepatotoxicity (Table 4), including Xbp1, Nfe2l2, Nr5a2, Ptf1a, Tp53 and Mycn. In particular, the two up-regulated Xbp1 and Nfe2l2 networks were highly enriched with P-values of 1.47E-16 and 4.73E-11 respectively, In the Xbp1 network, 38 target genes were found from the differentially expressed gene list and almost all of them (36) were up-regulated (Figure 3A), indicating that Xbp1 plays a central role in regulating a battery of genes responsible for protein trafficking and secretion [29]. In the Nfe2l2 network, 36 up- and 14 down-regulated genes were induced in the differentially expressed gene list (Figure 3B). This is in consistence with a previous study [30] that most of the regulated genes (such as mgst1, usp14, herpud1, dnajc3, actg1, hmox1, dnajb11, etc.) by Nfe2l2 are related to oxidative stress and mediate transcriptional events that facilitate protective responses in animal models exposed to xenobiotic.

Table 4. Most significant transcription factors in zebrafish liver after TCDD treatment.

GI_ID Gene Symbol Gene Name Regulation Z-Score P-value of Overlap
18859572 xbp1 X-box binding protein 1 4.07 1.47E-16
33504556 nfe2l2 nuclear factor (erythroid-derived 2)-like 2 2.45 4.73E-11
24158438 nr5a2 nuclear receptor subfamily 5, group A, member 2 −2.59 1.05E-03
124249093 ptf1a pancreas specific transcription factor, 1a −2.79 7.64E-06
18859502 tp53 tumor protein p53 −3.035 2.73E-02
47271377 mycn v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) −3.55 4.47E-04

Figure 3. Two most significant transcription factor networks in the zebrafish liver in response to TCDD exposure.

Figure 3

(A) Xbp1 network. (B) Nfe2l2 network, Target genes in the differentially expressed gene list (Table S1) are shown with red color indicating up-regulation and green color down-regulation. The intensity of the color corresponds to the relatively levels of up- and down-regulation.

Deregulated pathways in zebrafish livers treated by TCDD

To investigate the change of molecular pathways induced by TCDD treatment, GSEA was performed using the set of differentially expressed genes (651 up and 407 down) and 163 up- and 123 down-regulated pathways were identified (Table S3). Among all pathways, five up- and eight down-regulated pathways had significant FDR values less than 0.25 and are shown in Table 4. The first three pathways are associated with cell cycle progression, which have also been reported in mammalian models under TCDD stress [31], [32]. However in the present study, cell cycle and related pathways were significantly enhanced while some mammalian studies showed a decrease of these activities, suggesting different regulatory mechanism in various models as well as by different treatment regimes.

The mechanisms responsible for TCDD toxicity are always associated with its ability to disrupt endocrine functions. In our data, ubiquitin-proteasome pathway was significantly up-regulated in fish liver after TCDD treatment. Consistent with another study in the mammalian system [33], the up-regulated proteasome and related pathways in our study further indicated that the TCDD-induced ubiquitin-proteasomal degradation of AhR influenced the nucleus transcription by controlling the level of ligand-activated AhR. As ubiquitin-proteasome pathway is significantly induced in zebrafish and all mammalian models analyzed in our study, it is an apparently conserved mechanism of TCDD-induced toxicity between fish and mammals. Prostaglandin synthesis regulation pathway was suppressed in TCDD-treated zebrafish, consistent with a previous report that prostanoid synthesis pathway could be regulated by COX2-TBXS-TP (cyclooxygenase2-thromboxane A synthase1-thromboxane receptor) in zebrafish after TCDD treatment [34].

In the present study, several pathways related to signal transduction were significantly inhibited in zebrafish after TCDD treatment, including Ca2+ regulation pathways, Fas signaling pathway, T-cell signal transduction and T-cell receptor signaling pathway, ribosomal protein and its related pathways. TCDD has been reported to significantly increase intracellular free Ca2+ in many cell culture systems [35] and to trigger Ca2+-mediated endonuclease activity leading to apoptosis [36]. Our study, consistent with several previous reports [37][40], indicated that Ca2+ regulation pathways could be commonly involved in TCDD action. Furthermore, Fas signaling pathway, T-cell signal transduction and T-cell receptor signaling pathway were also suppressed in our study. Fas, a member of the tumor necrosis factor receptor (TNFR) family, contains a death domain which is essential for the delivery of the death signal [41]. Thus, Fas signaling regulation could be a mechanism of impaired T-cell related pathway induced by TCDD, which are consistent with another previous report [41]. Moreover, ribosomal proteins, in conjunction with rRNA, are involved in the cellular process of translation [42]. Interestingly, the ribosomal protein and its related pathway were down-regulated in zebrafish liver after TCDD exposure, but were induced in other mammalian models [43].

Furthermore, three immune-related pathways were significantly repressed in the zebrafish liver after TCDD exposure (Table 4), including natural killer cell mediated cytotoxicity, T-cell signal transduction and T-cell receptor signaling pathway. Moreover, several B-cell related pathways were also found to be inhibited with FDR>0.25 (Table S3). Collectively, our data indicate that hepatic immune-related functions were impaired in fish exposed to TCDD.

Toxicogenomic comparison between zebrafish and mammalian models

In order to gain insight into the common molecular toxicity of TCDD between fish and mammals as well as the validity of the zebrafish model to predict chemical toxicity for risk assessment for human health, our transcriptomic data were compared with available transcriptomic data from both in vivo and in vitro mammalian studies with TCDD. Among 26 related series in the GEO database using human cell lines, rat and mouse tissues and cells based on microarray studies, we found six series (GSE10082, GSE10083, GSE10769, GSE10770, GSE14555 and GSE34251) with effective comparability (Table 5) while other series were not included in the comparative analysis due to incompatibility in data uploading, platform, experimental strategy, etc. The list of 650 up-regulated genes from the current zebrafish study was used to represent the zebrafish transcriptome in GSEA. As shown in Figure 4A, based on normalized enrichment scores (NES) and false discovery rate (FDR), the zebrafish hepatic genes expression showed more resemblance to the in vivo models (average NES is 1.54) than in vitro models (average NES is 0.93). The comparison with all of the four in vivo data, FDR was smaller than 0.25, while none of the in vitro data showed such significance. These observations indicate that the zebrafish data is more similar to the in vivo mammalian data than in vitro data, further enforcing the validity of the zebrafish model as a potentially high-throughput and economic in vivo experimental models for studies relevant to human health.

Table 5. Detail information of GSE series from GEO database used in this study.

GSE series no. Animal models Treated concentrations Treated time Strategy
GSE10083 Rat, Rattus norvegicus (liver) 1000ug/kg 19h in vivo
GSE10770 Rat, Rattus norvegicus (liver) 1000ug/kg 19h in vivo
GSE10082 Mouse, Mus musculus (liver) 1000ug/kg 19h in vivo
GSE10769 Mouse, Mus musculus (liver) 1000ug/kg 19h in vivo
GSE14555 Rat, Rattus norvegicus (Primary Rat Hepatocytes) 10nM 48h in vitro
GSE34251 Rat, Rattus norvegicus (Primary Rat Hepatocytes) 10nM 24h in vitro
GSE14555 Human, Homo sapiens (Primary Human Hepatocytes) 10nM 48h in vitro
GSE34251 Human, Homo sapiens (Primary Human Hepatocytes) 10nM 24h in vitro

Figure 4. Comparative analyses of zebrafish and mammalian transcriptomic data from TCDD treatments.

Figure 4

(A) Correlation of hepatic transcriptome changes in the zebrafish with the mammalian in vivo and in vitro models by GSEA analysis. –Log2FDR = 2, that means FDR = 0.25. (B) Comparison of the pathways in zebrafish and the mammalian models by GSEA analysis. The heat map includes the significant pathways in zebrafish and mammalian models treated by TCDD, the criteria of zebrafish pathways is FDR<0.25.

To further analyze the correlation of zebrafish and other mammalian models after TCDD treatment, comparison of pathways were made by GSEA pre-ranked function. One up-regulated (Proteasome pathway) and three down-regulated pathways (HSA04650 Natural killer cell mediated cytotoxicity, HSA04660 T cell receptor signaling pathway, HSA04020 Calcium signaling pathway) in zebrafish showed the same regulation direction as those in all other mammalian models, indicating that the four pathways were well conserved in vertebrates. Meanwhile, HSA03010 Ribosome pathway displayed completely opposite regulated trends between zebrafish and all mammalian models we compared (Figure 4B), indicating the species-specific patterns between fish and mammals after TCDD treatment, which need further analysis in future. Moreover, after comparing the conserved pathways (the same regulation direction pathways) among zebrafish model, in vivo and in vitro mammalian models, we noted that the degree of regulation is more consistent between the zebrafish and in vivo mammalian models than between the zebrafish and in vitro mammalian models, as indicated by the color codes in Figure 4B.

In summary, by RNA-sequencing based transcriptomic analyses, we have carried out detailed analyses of TCDD-induced molecular changes in zebrafish. Other than the well characterized AhR pathway and cyp1a1 biomarker gene induced by TCDD, we also found some new biomarker genes that have been validated from independent experiments. Interestingly, some of the new biomarker genes encode secreted proteins such as Fgf13b, Sdf2 and RNasel2, which may by analyzed from serum samples by a non-invasive approach. Further and comparative transcriptomic analyses of our zebrafish data and available mammalian data from TCDD treatment experiments indicate several well conserved TCDD-responsive pathways, including up-regulated proteomic pathway and several down regulated pathways such as calcium signaling pathway, natural killer cell mediated cytotoxicity, T-cell receptor signaling pathway etc. Furthermore, GSEA analyses indicate that the TCDD-induced zebrafish transcriptomic data is more similar to in vivo mammalian data than in vitro data, thus indicating the validity of the zebrafish model as a valuable in vivo model to infer molecular toxicity relevant to human health.

Supporting Information

Table S1

Complete list of differentially expressed genes in zebrafish liver exposed to TCDD with a cut off of fold change>2 and TPM >10.

(XLSX)

Table S2

Up-regulated CYP family genes in zebrafish treated by TCDD.

(XLSX)

Table S3

Complete list of pathways in zebrafish exposed to TCDD as revealed by GSEA analysis.

(XLSX)

Funding Statement

This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB (grant number R-154-000-328-272). The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.

References

  • 1. Ovando BJ, Ellison CA, Vezina CM, Olson JR (2010) Toxicogenomic analysis of exposure to TCDD, PCB126 and PCB153: identification of genomic biomarkers of exposure to AhR ligands. BMC Genomics 11: 583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Mandal PK (2005) Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J Comp Physiol B 175: 221–230. [DOI] [PubMed] [Google Scholar]
  • 3. Consonni D, Sindaco R, Bertazzi PA (2012) Blood levels of dioxins, furans, dioxin-like PCBs, and TEQs in general populations: A review, 1989–2010. Environ Int 44: 151–162. [DOI] [PubMed] [Google Scholar]
  • 4. Black MB, Budinsky RA, Dombkowski A, Cukovic D, LeCluyse EL, et al. (2012) Cross-species comparisons of transcriptomic alterations in human and rat primary hepatocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci 127: 199–215. [DOI] [PubMed] [Google Scholar]
  • 5. Ryu YM, Kim KN, Kim YR, Sohn SH, Seo SH, et al. (2005) Gene expression profiles related with TCDD-induced hepatotoxicity. Mol Cell Toxicol 1: 164–171. [Google Scholar]
  • 6. Cao ZJ, Tanguay RL, McKenzie D, Peterson RE, Aiken JM (2003) Identification of a putative calcium-binding protein as a dioxin-responsive gene in zebrafish and rainbow trout. Aquat Toxicol 63: 271–282. [DOI] [PubMed] [Google Scholar]
  • 7. Volz DC, Bencic DC, Hinton DE, Law JM, Kullman SW (2005) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces organ-specific differential gene expression in male Japanese medaka (Oryzias latipes). Toxicol Sci 85: 572–584. [DOI] [PubMed] [Google Scholar]
  • 8. Su ZQ, Li ZG, Chen T, Li QZ, Fang H, et al. (2011) Comparing next-generation sequencing and microarray technologies in a toxicological study of the effects of aristolochic acid on rat kidneys. Chem Res Toxicol 24: 1486–1493. [DOI] [PubMed] [Google Scholar]
  • 9. Davey JW, Hohenlohe PA, Etter PD, Boone JQ, Catchen JM, et al. (2011) Genome-wide genetic marker discovery and genotyping using next-generation sequencing. Nat Rev Genet 12: 499–510. [DOI] [PubMed] [Google Scholar]
  • 10. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y (2008) RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 18: 1509–1517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Metzker ML (2010) Sequencing technologies – the next generation. Nat Rev Genet 11: 31–46. [DOI] [PubMed] [Google Scholar]
  • 12. Kasahara M, Naruse K, Sasaki S, Nakatani Y, Qu W, et al. (2007) The medaka draft genome and insights into vertebrate genome evolution. Nature 447: 714–719. [DOI] [PubMed] [Google Scholar]
  • 13. Venkatesh B (2003) Evolution and diversity of fish genomes. Curr Opin Genet Dev 13: 588–592. [DOI] [PubMed] [Google Scholar]
  • 14. Lam SH, Wu YL, Vega VB, Miller LD, Spitsbergen J, et al. (2006) Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol 24: 73–75. [DOI] [PubMed] [Google Scholar]
  • 15. Pichler FB, Laurenson S, Williams LC, Dodd A, Copp BR, et al. (2003) Chemical discovery and global gene expression analysis in zebrafish. Nat Biotechnol 21: 879–883. [DOI] [PubMed] [Google Scholar]
  • 16. Guo L, Lobenhofer EK, Wang C, Shippy R, Harris SC, et al. (2006) Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol 24: 1162–1169. [DOI] [PubMed] [Google Scholar]
  • 17. Shi LM, Reid LH, Jones WD, Shippy R, Warrington JA, et al. (2006) The microarray quality control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24: 1151–1161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Hegedus Z, Zakrzewska A, Agoston VC, Ordas A, Racz P, et al. (2009) Deep sequencing of the zebrafish transcriptome response to mycobacterium infection. Molecular Immunology 46: 2918–2930. [DOI] [PubMed] [Google Scholar]
  • 19. Zheng W, Wang Z, Collins JE, Andrews RM, Stemple D, et al. (2011) Comparative transcriptome analyses indicate molecular homology of zebrafish swimbladder and mammalian lung. PLoS One 6: e24019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Kim S, Dere E, Burgoon LD, Chang CC, Zacharewski TR (2009) Comparative analysis of AhR-mediated TCDD-elicited gene expression in human liver adult stem cells. Toxicol Sci 112: 229–244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Ruiz-Aracama A, Peijnenburg A, Kleinjans J, Jennen D, van Delft J, et al. (2011) An untargeted multi-technique metabolomics approach to studying intracellular metabolites of HepG2 cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. BMC Genomics 12: 251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Forgacs AL, Kent MN, Makley MK, Mets B, DelRaso N, et al. (2012) Comparative metabolomic and genomic analyses of TCDD-elicited metabolic disruption in mouse and rat liver. Toxicol Sci 125: 41–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. May BK, Dogra SC, Sadlon TJ, Bhasker CR, Cox TC, et al. (1995) Molecular regulation of heme-biosynthesis in higher vertebrates. Prog Nucl Res Molec Biol 51: 1–51. [DOI] [PubMed] [Google Scholar]
  • 24. Falahatpisheh H, Nanez A, Montoya-Durango D, Qian YC, Tiffany-Castiglioni E, et al. (2007) Activation profiles of HSPA5 during the glomerular mesangial cell stress response to chemical injury. Cell Stress Chaperones 12: 209–218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Boverhof DR, Burgoon LD, Tashiro C, Chittim B, Harkema JR, et al. (2005) Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-mediated hepatotoxicity. Toxicol Sci 85: 1048–1063. [DOI] [PubMed] [Google Scholar]
  • 26. Zodrow JM, Stegeman JJ, Tanguay RL (2004) Histological analysis of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in zebrafish. Aquat Toxicol 66: 25–38. [DOI] [PubMed] [Google Scholar]
  • 27.Jo H, Choe SS, Shin KC, Jang H, Lee JH, et al. (2012) ER stress induces hepatic steatosis via increased expression of the hepatic VLDL receptor. Hepatology DOI: 10.1002/hep.26126. [DOI] [PubMed]
  • 28. Gentile CL, Frye M, Pagliassotti MJ (2011) Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease. Antioxid Redox Signal 15: 505–521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Shaffer AL, Shapiro-Shelef M, Iwakoshi NN, Lee AH, Qian SB, et al. (2004) XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21: 81–93. [DOI] [PubMed] [Google Scholar]
  • 30. Xu SH, Weerachayaphorn J, Cai SY, Soroka CJ, Boyer JL (2010) Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression. Am J Physiol-Gastroint Liver Physiol 299: G126–G135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Dere E, Boverhof DR, D Burgoon L, Zacharewski TR (2006) In vivo – in vitro toxicogenomic comparison of TCDD-elicited gene expression in HepaIcIc7 mouse hepatoma cells and C57BL/6 hepatic tissue. BMC Genomics 7. [DOI] [PMC free article] [PubMed]
  • 32. Marlowe JL, Knudsen ES, Schwemberger S, Puga A (2004) The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression. J Biol Chem 279: 29013–29022. [DOI] [PubMed] [Google Scholar]
  • 33. Ma Q, Baldwin KT (2000) 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway – Role of the transcription activaton and DNA binding of AhR. J Biol Chem 275: 8432–8438. [DOI] [PubMed] [Google Scholar]
  • 34.Teraoka H, Kubota A, Kawai Y, Hiraga T (2008) Prostanoid signaling mediates circulation failure caused by TCDD in developing zebrafish. Biological Responses to Chemical Pollutants, in: Murakami, H, Nakayama, K, Kitamura, SI, Iwata, H and Tanabe, S (Eds), Interdisciplinary Studies on Environmental Chemistry Terra Pub, Tokyo, 61–80.
  • 35. Puga A, Hoffer A, Zhou SY, Bohm JM, Leikauf GD, et al. (1997) Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem Pharmacol 54: 1287–1296. [DOI] [PubMed] [Google Scholar]
  • 36. Mcconkey DJ, Hartzell P, Duddy SK, Hakansson H, Orrenius S (1988) 2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca2+-mediated endonuclease activation. Science 242: 256–259. [DOI] [PubMed] [Google Scholar]
  • 37. Cantrell SM, Lutz LH, Tillitt DE, Hannink M (1996) Embryotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): The embryonic vasculature is a physiological target for TCDD-induced DNA damage and apoptotic cell death in medaka (Orizias latipes). Toxicol Appl Pharmacol 141: 23–34. [DOI] [PubMed] [Google Scholar]
  • 38. Toomey BH, Bello S, Hahn ME, Cantrell S, Wright P, et al. (2001) 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces apoptotic cell death and cytochrome P4501A expression in developing Fundulus heteroclitus embryos. Aquat Toxicol 53: 127–138. [DOI] [PubMed] [Google Scholar]
  • 39. Dong W, Teraoka H, Yamazaki K, Tsukiyama S, Imani S, et al. (2002) 2,3,7,8-Tetrachlorodibenzo-p-dioxin toxicity in the zebrafish embryo: Local circulation failure in the dorsal midbrain is associated with increased apoptosis. Toxicol Sci 69: 191–201. [DOI] [PubMed] [Google Scholar]
  • 40. Chen YH, Tukey RH (1996) Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J Biol Chem 271: 26261–26266. [DOI] [PubMed] [Google Scholar]
  • 41. Dearstyne EA, Kerkvliet NI (2002) Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced decrease in anti-CD3-activated CD4(+) T cells: the roles of apoptosis, Fas, and TNF. Toxicology 170: 139–151. [DOI] [PubMed] [Google Scholar]
  • 42. Komili S, Farny NG, Roth FP, Silver PA (2007) Functional specificity among ribosomal proteins regulates gene expression. Cell 131: 557–571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Handley-Goldstone HM, Grow MW, Stegeman JJ (2005) Cardiovascular gene expression profiles of dioxin exposure in zebrafish embryos. Toxicol Sci 85: 683–693. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Table S1

Complete list of differentially expressed genes in zebrafish liver exposed to TCDD with a cut off of fold change>2 and TPM >10.

(XLSX)

Table S2

Up-regulated CYP family genes in zebrafish treated by TCDD.

(XLSX)

Table S3

Complete list of pathways in zebrafish exposed to TCDD as revealed by GSEA analysis.

(XLSX)


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES